Clinical Bacteriology and Mycology, Ethiopian Public Health Institute Ethiopia, Addis Ababa, Ethiopia.
Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, United States of America.
PLoS One. 2020 Jun 1;15(6):e0233753. doi: 10.1371/journal.pone.0233753. eCollection 2020.
Neisseria gonorrhoeae (gonococcus) is the etiologic agent for the sexually transmitted Infection gonorrhea, a disease with a significant global public health impact. The treatment regimen for gonorrhea has been changed frequently over the past few decades due to the organism's propensity for developing antibiotic resistance. This study investigated antimicrobial susceptibility patterns of quinolones, third-generation cephalosporin, and other relevant antimicrobials found in N. gonorrhoeae isolated from men presenting with urethral discharge at selected healthcare facilities in Addis Ababa, Ethiopia, with the aim of revising the national treatment regimen based on the information generated from this study.
A total of 599 male patients presenting with urethral discharge were included in the current study. Urethral discharge specimens were cultured on Modified Thayer Martín media and suspected gonococcal colonies were confirmed using Oxidase and Superoxol tests followed by identification through a commercial kit (API-NHR). Antimicrobial susceptibility testing was performed by the Kirby-Bauer disc diffusion method using ciprofloxacin (5μg), ceftriaxone (30μg), cefixime (5μg), cefoxitin (30 μg), penicillin (10μg) and spectinomycin (100 μg) on enriched GC agar. Minimum Inhibitory Concentration (MIC) was also carried out using concentration gradient strips (E-tests) of the same antimicrobial agents.
The prevalence of gonococcal isolates in the current study was 69%. Out of the 361 gonococcal isolates, close to 68% were fluoroquinolone non-susceptible, with 60% resistant and 7% having an intermediate status. However, all tested isolates were susceptible to ceftriaxone. In addition, all of the isolates have shown reduced non-susceptibility to spectinomycin and cefoxitin.
The prevalence of gonococcal isolates in men presenting with urethral discharge at selected healthcare facilities in Addis Ababa, Ethiopia was found to be high. The high level of fluoroquinolone resistance observed in gonococcal isolates recovered in this study necessitates revision of the national syndromic treatment guideline.
淋病奈瑟菌(淋球菌)是性传播感染淋病的病原体,对全球公共卫生有重大影响。由于该生物体易产生抗生素耐药性,过去几十年中,淋病的治疗方案经常发生变化。本研究旨在根据该研究提供的信息修订国家治疗方案,因此调查了在埃塞俄比亚亚的斯亚贝巴选定医疗机构就诊的出现尿道分泌物的男性中分离出的淋病奈瑟菌对喹诺酮类、第三代头孢菌素和其他相关抗菌药物的药敏模式。
本研究共纳入 599 例出现尿道分泌物的男性患者。将尿道分泌物标本接种于改良 Thayer-Martin 培养基,用氧化酶和 Superoxol 试验对疑似淋球菌进行确认,然后使用商业试剂盒(API-NHR)进行鉴定。采用 Kirby-Bauer 纸片扩散法对环丙沙星(5μg)、头孢曲松(30μg)、头孢克肟(5μg)、头孢西丁(30μg)、青霉素(10μg)和壮观霉素(100μg)进行药敏试验在 GC 琼脂上进行。还使用相同抗菌药物的浓度梯度条(E-试验)进行最低抑菌浓度(MIC)检测。
本研究中淋病奈瑟菌的分离率为 69%。在 361 株淋病奈瑟菌分离株中,近 68%的菌株对氟喹诺酮类药物不敏感,其中 60%耐药,7%为中介。然而,所有测试的分离株均对头孢曲松敏感。此外,所有分离株对壮观霉素和头孢西丁的非敏感性均降低。
在埃塞俄比亚亚的斯亚贝巴选定医疗机构就诊的出现尿道分泌物的男性中,淋病奈瑟菌分离株的流行率很高。本研究中回收的淋病奈瑟菌分离株中观察到高水平的氟喹诺酮类耐药性,需要修订国家综合征治疗指南。